A pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with brain metastases (BMs) from DESTINY-Breast (DB)-01,-02, and-03 Meeting Abstract
| Authors: | Hurvitz, S. A.; Modi, S.; Li, W.; Park, Y. H.; Chung, W.; Kim, S. B.; Cortés, J.; Yamashita, T.; Pedrini, J.; Im, S. A.; Tseng, L. M.; Harbeck, N.; Krop, I.; Curigliano, G.; Mathias, E.; Cathcart, J.; Cagnazzo, A.; Ashfaque, S.; Egorov, A.; André, F. |
| Abstract Title: | A pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with brain metastases (BMs) from DESTINY-Breast (DB)-01,-02, and-03 |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S335 |
| End Page: | S336 |
| Language: | English |
| ACCESSION: | WOS:001087480200366 |
| DOI: | 10.1016/j.annonc.2023.09.554 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 377O-- Source: Wos |
